ID: ALA5080755

Max Phase: Preclinical

Molecular Formula: C52H69N7O7S

Molecular Weight: 936.23

Molecule Type: Unknown

Associated Items:

Representations

Canonical SMILES:  Cc1ncsc1-c1ccc(CNC(=O)[C@@H]2C[C@@H](O)CN2C(=O)[C@H](NC(=O)C2(C)CC2)C(C)(C)C)c(OCCCCCCCCCCCC(=O)Nc2ccc(C(=O)Nc3ccccc3N)cc2)c1

Standard InChI:  InChI=1S/C52H69N7O7S/c1-34-45(67-33-55-34)36-20-21-37(31-54-48(63)42-30-39(60)32-59(42)49(64)46(51(2,3)4)58-50(65)52(5)26-27-52)43(29-36)66-28-16-12-10-8-6-7-9-11-13-19-44(61)56-38-24-22-35(23-25-38)47(62)57-41-18-15-14-17-40(41)53/h14-15,17-18,20-25,29,33,39,42,46,60H,6-13,16,19,26-28,30-32,53H2,1-5H3,(H,54,63)(H,56,61)(H,57,62)(H,58,65)/t39-,42+,46+/m1/s1

Standard InChI Key:  ORWXCOUYCBSWFL-XASURKDDSA-N

Associated Targets(Human)

VHL/Histone deacetylase 1 90 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

VHL/Histone deacetylase 2 81 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

VHL/Histone deacetylase 3 77 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 936.23Molecular Weight (Monoisotopic): 935.4979AlogP: 8.78#Rotatable Bonds: 23
Polar Surface Area: 205.08Molecular Species: NEUTRALHBA: 10HBD: 6
#RO5 Violations: 3HBA (Lipinski): 14HBD (Lipinski): 7#RO5 Violations (Lipinski): 4
CX Acidic pKa: 12.28CX Basic pKa: 3.24CX LogP: 7.10CX LogD: 7.10
Aromatic Rings: 4Heavy Atoms: 67QED Weighted: 0.03Np Likeness Score: -0.59

References

1. Smalley JP, Baker IM, Pytel WA, Lin LY, Bowman KJ, Schwabe JWR, Cowley SM, Hodgkinson JT..  (2022)  Optimization of Class I Histone Deacetylase PROTACs Reveals that HDAC1/2 Degradation is Critical to Induce Apoptosis and Cell Arrest in Cancer Cells.,  65  (7.0): [PMID:35293758] [10.1021/acs.jmedchem.1c02179]

Source